Skip to content

Trial Summary

Pan Tumor Study for Long Term Follow-up of Cancer Survivors Who Have Participated in Trials Investigating Nivolumab

Acronym:

CA209-8TT

ACTRN/NCT /ethics:

NCT03899155

Scientific title:

Main Objective of this study is to examine long-term safety of nivolumab in participants on treatment and in follow up.

Sponsor / Cooperative group:

Bristol-Myers Squibb

Trial & Patient Characteristics

Cancer TypeAll cancers
Trial TypeTreatment
PhasePhase II
Age Range18 years and older
SexBoth
Tumour Stream -
Cancer Stage-
Anticipated Start Date2019-06-27
Anticipated End Date2025-08-25

Participating Hospitals

HospitalLyell McEwin Hospital
Clinical Trial CoordinatorAndy Phay
Emailandy.phay@sa.gov.au
Phone08 8282 0833
Principal InvestigatorDr Christopher Hocking
Recruitment StatusRecruiting